These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 28890884)
21. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640 [TBL] [Abstract][Full Text] [Related]
22. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. Lin X; Wang Z; Wang Y; Feng W Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789 [TBL] [Abstract][Full Text] [Related]
23. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer. Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956 [TBL] [Abstract][Full Text] [Related]
24. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Sharifi M; Salehi R Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357 [TBL] [Abstract][Full Text] [Related]
25. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
26. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
27. Role of mesenchymal stem cells exosomes derived microRNAs; miR-136, miR-494 and miR-495 in pre-eclampsia diagnosis and evaluation. Motawi TMK; Sabry D; Maurice NW; Rizk SM Arch Biochem Biophys; 2018 Dec; 659():13-21. PubMed ID: 30261165 [TBL] [Abstract][Full Text] [Related]
28. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia. Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic significance of serum miR-203 in patients with acute myeloid leukemia. Zheng Z; Rong G; Li G; Ren F; Ma Y Int J Clin Exp Pathol; 2019; 12(5):1548-1556. PubMed ID: 31933972 [TBL] [Abstract][Full Text] [Related]
30. Potential role of plasma miR-21 and miR-92a in distinguishing between irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Ahmed Hassan E; El-Din Abd El-Rehim AS; Mohammed Kholef EF; Abd-Elgwad Elsewify W Gastroenterol Hepatol Bed Bench; 2020; 13(2):147-154. PubMed ID: 32308936 [TBL] [Abstract][Full Text] [Related]
31. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727 [TBL] [Abstract][Full Text] [Related]
32. The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study. Elshafei A; Shaker O; Abd El-Motaal O; Salman T Tumour Biol; 2017 Jun; 39(6):1010428317705765. PubMed ID: 28618945 [TBL] [Abstract][Full Text] [Related]
33. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening. Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS Oncology; 2019; 97(3):173-179. PubMed ID: 31216561 [TBL] [Abstract][Full Text] [Related]
34. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
35. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia. Guo Y Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of miR-92a in asymptomatic carotid artery stenosis patients and its ability to predict cerebrovascular events. Chen G; Gao J; Sheng Y; Han X; Ji X; Zhao M; Wu J Diagn Pathol; 2020 Jun; 15(1):74. PubMed ID: 32522208 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia. Sharifi M; Salehi R; Gheisari Y; Kazemi M Adv Biomed Res; 2014; 3():61. PubMed ID: 24627869 [TBL] [Abstract][Full Text] [Related]
40. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]